Martin-Malo et al., 1989 - Google Patents
Factors affecting β2-microglobulin plasma concentration during hemodialysisMartin-Malo et al., 1989
- Document ID
- 1382410833484565278
- Author
- Martin-Malo A
- Mallol J
- Castillo D
- Barrio V
- Burdiel L
- Perez R
- Aljama P
- Publication year
- Publication venue
- The International Journal of Artificial Organs
External Links
Snippet
We studied ten patients on hemodialysis (HD) treated in sequence with cuprophan (CU), ethylenevinylalcohol (EVAL), polyacrylonitrile (A-69) and polysulphone (PSP) membrane dialyzers. ß2-microglobulin (ß2m) was measured by radioimmunoassay in plasma and …
- 238000001631 haemodialysis 0 title abstract description 40
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators; Reciprocating systems for treatment of body fluids, e.g. single needle systems for haemofiltration, pheris
- A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators; Reciprocating systems for treatment of body fluids, e.g. single needle systems for haemofiltration, pheris with membranes
- A61M1/1601—Control or regulation
- A61M1/1603—Regulation parameters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. haemofiltration, diafiltration
- A61M1/3472—Filtering material out of the blood by passing it through a membrane, i.e. haemofiltration, diafiltration with treatment of the filtrate
- A61M1/3486—Biological, chemical treatment, e.g. chemical precipitation; treatment by absorbents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. haemofiltration, diafiltration
- A61M1/342—Adding solutions to the blood, e.g. substitution solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation; Extra-corporeal blood circuits
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/75—General characteristics of the apparatus with filters
- A61M2205/7563—General characteristics of the apparatus with filters with means preventing clogging of filters
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Zingraff et al. | Influence of Haemodialysis Membranes on β2-Microlobulin Kinetics: In Vivo and In Vitro Studies | |
| Varela et al. | Biocompatibility of hemodialysis membranes: interrelations between plasma complement and cytokine levels | |
| Röckel et al. | Elimination of low molecular weight proteins during hemofiltration | |
| Martin-Malo et al. | Factors affecting β2-microglobulin plasma concentration during hemodialysis | |
| Canaud et al. | ß-2Microglobulin Serum Levels in Maintenance Dialysis | |
| France et al. | β2-Microglobulin Serum Levels in Patients on Long Term Dialysis | |
| Rubin et al. | Evaluation of continuous ambulatory peritoneal dialysis | |
| Jørstad | Biocompatibility of different hemodialysis and plasmapheresis membranes | |
| Kandus et al. | Beta 2-microglobulin elimination characteristics during hemofiltration with acrylonitrile and polysulfone membrane hemofilters | |
| Honkanen et al. | Clinical testing of a new, low-flux polysulfone membrane: results of a 26-week study | |
| Klinke et al. | Beta-2-microglobulin adsorption and release in-vitro: influence of membrane material, osmolality and heparin | |
| Cicchetti et al. | Dialysis treatment using an ethylene vinyl alcohol membrane and no anticoagulation for chronic uremic patients | |
| HOSOKAWA | Changes of serum silicon levels by hemodialysis | |
| Moran | Use of the LifeSite® hemodialysis access system improves blood flow and access patency | |
| Forêt et al. | Evaluation and Tolerance of a New Polycarbonate Membrane in Elderly Patients: Preliminary Results | |
| Held et al. | Survival among dialysis patients in for-profit and not-for-profit hemodialysis (HD) facilities | |
| Ronco et al. | Technical and Clinical Evaluation of a New Low Flux Polysulphon Membrane | |
| Scorgie et al. | Middle molecule adsorption from ultrafiltrate for use in intensive care medicine | |
| Liao et al. | Modeling of Dialysate Flow in an Artificial Kidney: A Porous Media Model | |
| Andersen et al. | Clinical experience with a new high-ultrafiltration hemofilter | |
| Sieberth | Influence of Coagulation Parameters on Filter Running Time during Continuous | |
| Huang et al. | Evaluation of hemodialyzer performance at different concentric annular regions | |
| Kumar et al. | Extended daily dialysis (EDD) rapidly reduces serum phosphate levels in intensive care unit (ICU) patients with acute renal failure (ARF) | |
| HEMOFILTRATION et al. | P48 RISK PREDICTION IN MOSF PTS WITH ACUTE RENAL FAILURE: APACHE II SCORE VS APACHE III | |
| Klarenbach et al. | Reduced requirement for erythropoietin with quotidian hemodialysis therapy |